Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02753985 · ClinicalTrials.gov registry record
Adherence to Aromatase Inhibitors: The Role of Partners
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 40
- Enrollment target
NCT02753985 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 40 participants.
The verdict
NCT02753985 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This is a qualitative study which explores the role that partners play in breast cancer survivors adherence to aromatase inhibitors and management of their side effects. Both patients and their partners will be interviewed (separately) in order to capture multiple perspectives. The target number of subjects is 64 (32 patients and 32 partners). The primary method of data collection will be face-to-face semi-structured interviews. These interviews will be audio-recorded.
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-04-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02753985
The ClinicalTrials.gov registry entry for NCT02753985 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT02753985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02753985 about?
NCT02753985 is a clinical study titled "Adherence to Aromatase Inhibitors: The Role of Partners". This is a qualitative study which explores the role that partners play in breast cancer survivors adherence to aromatase inhibitors and management of their side effects. Both patients and their partners will be interviewed (separately) in order to capture multiple perspectives. The target number of ...
What is the current status of trial NCT02753985?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2014-07. Estimated completion is 2016-04-22.
What interventions are being tested in trial NCT02753985?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT02753985?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.